247 related articles for article (PubMed ID: 19530745)
1. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
[TBL] [Abstract][Full Text] [Related]
2. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
3. Cataracts and statins. A disproportionality analysis using data from VigiBase.
Macías Saint-Gerons D; Bosco Cortez F; Jiménez López G; Castro JL; Tabarés-Seisdedos R
Regul Toxicol Pharmacol; 2019 Dec; 109():104509. PubMed ID: 31669197
[TBL] [Abstract][Full Text] [Related]
4. Statins and immune-mediated necrotizing myopathy: Variability in the risk.
Trenque T; Hadjoudj J; Trenque A; Tralongo F; Martin S; Azzouz B
Therapie; 2024; 79(3):365-370. PubMed ID: 37625939
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
[TBL] [Abstract][Full Text] [Related]
6. HMG CoA reductase inhibitors and impotence: two case series from the Spanish and French drug monitoring systems.
Carvajal A; Macias D; Sáinz M; Ortega S; Martín Arias LH; Velasco A; Bagheri H; Lapeyre-Mestre M; Montastruc JL
Drug Saf; 2006; 29(2):143-9. PubMed ID: 16454541
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database.
Moulis G; Béné J; Sommet A; Sailler L; Lapeyre-Mestre M; Montastruc JL;
Lupus; 2012 Jul; 21(8):885-9. PubMed ID: 22333565
[TBL] [Abstract][Full Text] [Related]
8. Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase
Montastruc F; Benevent J; Rousseau V; Durrieu G; Sommet A; Montastruc JL
Fundam Clin Pharmacol; 2019 Feb; 33(1):108-112. PubMed ID: 30098074
[TBL] [Abstract][Full Text] [Related]
9. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
[TBL] [Abstract][Full Text] [Related]
10. Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system.
Xiao M; Li L; Zhu W; Wu F; Wu B
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):255-261. PubMed ID: 38275183
[TBL] [Abstract][Full Text] [Related]
11. Hepatic adverse drug reactions: a case/non-case study in Italy.
Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins.
Montastruc JL
Br J Clin Pharmacol; 2023 Aug; 89(8):2636-2638. PubMed ID: 37186323
[TBL] [Abstract][Full Text] [Related]
13. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.
Capogrosso Sansone A; Convertino I; Galiulo MT; Salvadori S; Pieroni S; Knezevic T; Mantarro S; Marino A; Hauben M; Blandizzi C; Tuccori M
Drug Saf; 2017 Oct; 40(10):895-909. PubMed ID: 28681266
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P
Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S
Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743
[TBL] [Abstract][Full Text] [Related]
16. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting.
Trenque T; Maura G; Herlem E; Vallet C; Sole E; Auriche P; Drame M
Drug Saf; 2013 Jul; 36(7):515-9. PubMed ID: 23728950
[TBL] [Abstract][Full Text] [Related]
17. Muscle Damage Due to Fusidic Acid-Statin Interaction: Review of 75 Cases From the French Pharmacovigilance Database and Literature Reports.
Bataillard M; Beyens MN; Mounier G; Vergnon-Miszczycha D; Bagheri H; Cathebras P
Am J Ther; 2019; 26(3):e375-e379. PubMed ID: 29189310
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
Strandell J; Bate A; Hägg S; Edwards IR
Br J Clin Pharmacol; 2009 Sep; 68(3):427-34. PubMed ID: 19740401
[TBL] [Abstract][Full Text] [Related]
19. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
Fraunfelder FW; Richards AB
Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-related adverse events associated with statins: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS).
Wu T; Shi Y; Zhu B; Li D; Li Z; Zhao Z; Zhang Y
Expert Opin Drug Saf; 2024 Mar; 23(3):313-321. PubMed ID: 37612600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
